ºÚÁÏÍø

The NIH-funded Duke University and the University of North Carolina Alzheimer’s Disease Research Center () brings together leading researchers in Alzheimer’s disease and related dementias across two major research institutions. Specifically, we aim to catalyze and support research, innovations in clinical care and academic work force development (with North Carolina Central University, East Carolina University and ºÚÁÏÍø Pembroke as partner institutions) in this field.

Ultimately, our purpose is to reduce the burden of Alzheimer’s disease and related dementias regionally and nationally. The outstanding scientific environment at both institutions enables novel research to identify effective methods of prevention and/or early intervention, and to reduce racial and urban/rural disparities associated with dementia.

Through a 2018 grant from the Duke Endowment, the Division launched a ground-breaking program to transform hospitals into dementia-friendly centers of care. The Duke Endowment-funded Dementia Friendly Hospital Initiative program brings comprehensive dementia-friendly training to four ºÚÁÏÍø Healthcare Hospitals. In addition, it serves as a blueprint for program expansion both regionally and nationally. ºÚÁÏÍø Hospitals Hillsborough Campus is the pilot site for hospital-wide training of all staff and clinicians who interact with patients with dementia.

The Carolina Geriatric Workforce Enhancement Program (GWEP) funded by HRSA, is led by Project Director, Jan Busby-Whitehead, MD. The CGWEP integrates geriatric principles and interprofessional teamwork to address the 4Ms of age-friendly health systems (What Matters to older adults, Medication, Mentation, and Mobility) and to address dementia-friendly care. Academic partners and NC AHECs are providing both in person and virtual training and consultation to tribal organizations, rural and underserved primary care sites to better integrate age-friendly and dementia-friendly content into practices and health care systems.

Division Chief Dr. Jan Busby-Whitehead is Co-Investigator and Dissemination Task Force Co-Leader for the NIA’s . NIDUS gathers data on all delirium research, grants, and studies worldwide, and advocates to advance delirium research and understanding. NIDUS has five Cores:

• Delirium Research Hub – Focuses on improving research collaboration
• Measurement & Harmonization – Develops delirium measurement resources
• Pilot Awards & Innovation – Encourages new delirium research
• Mentoring & Career Development – Trains and develops future delirium researchers
• Dissemination & Communication – Communicates news on delirium research

Dr. Adrian Austin (MD, MCSR) is a delirium researcher who is dually board certified in Geriatric Medicine and Critical Care / Pulmonary Medicine. Additionally, he has two pilot projects on delirium: a tablet-based delirium assessment tool for home use and a pharmacogenomic study of dose and response variability among mechanically ventilated ICU patients.

As adults age, it is important to reconsider the risks and benefits of medications. Many medications that were once appropriate no longer hold the same benefit as the risk for side effects increases. Deprescribing is the gradual reduction of medications when the benefits no longer outweigh the potential harms. Undoubtedly, it is a cornerstone of geriatrics clinical practice to optimize care for older adults. Deprescribing is a rapidly growing area of research in geriatric medicine. As such, the Division of Geriatrics, and the Center for Aging and Health is quickly becoming a hub these projects.

, Vice Chair of the Division of Practice Advancement and Clinical Education at the ºÚÁÏÍø Eshelman School of Pharmacy and Geriatric Medicine Division Chief Jan Busby-Whitehead, MD, are co-Principal Investigators of a CDC-funded grant on screening older adults who use prescription opioids and are at risk for falls. The study will engage patients 65 years and older within the ºÚÁÏÍø Health Care system. Specifically, these are patients who are taking either an opioid or benzodiazepine. Accordingly, a centralized team of clinical pharmacists will screen patients. In the end, the team will provide recommendations on deprescribing these medications with the goal of reducing the risk for future falls.

Dr. Ferreri also led a 2016 CDC-funded grant on implementing an integrative falls prevention program for which Dr. Busby-Whitehead is a Co-Investigator. This work led to the development of . This guide helps improve collaboration between prescribers and pharmacists to screen patients and intervene to reduce falls risk.

Joshua Niznik, PharmD, PhD, Assistant Professor of Medicine, leads a program of research in geriatric medicine aimed at medication optimization for nursing home residents with dementia. He leverages large healthcare databases including electronic health records, Medicare claims, and VA Healthcare System data to conduct pharmacoepidemiologic analyses examining patterns of medication use and health-related outcomes.

In 2020-2021, Dr. Niznik was a member of the US Deprescribing Network Junior Investigator Initiative. Also, he was awarded a USDN pilot grant to evaluate deprescribing of bisphosphonates. This led to his five-year K08 Mentored Clinical Scientist Development Award from the National Institutes on Aging. Dr. Niznik also collaborates with Eshelman School of Pharmacy faculty member Carolyn Thorpe, PhD, MPH, to evaluate medication de-intensification in older Veteran nursing home residents near end of life.

Learn more about Dr. John Batsis, his team, and their research on Physical Function, Obesity, and other topics.

With funding from a Tier 2 Clinical / Translational Award from the ºÚÁÏÍø Lineberger Comprehensive Cancer Center, Laura Hanson, MD, MPH, and other Geriatrics, Palliative Care and Oncology faculty have developed and begun testing a collaborative palliative care model for patients with Stage IV cancer. Specifically, the research tests an innovative approach to support continuity of care between inpatient and outpatient providers. It also facilitates efficient and targeted use of specialty Palliative Care.

With funding from the Gordon and Betty Moore Foundation, Chrissy Kistler, MD, and Laura C. Hanson, MD, are Co-Principal Investigators for a 2-year project on Improving Primary Care Clinicians’ Communication Skills in Dementia Palliative Care. Advance care planning decisions are particularly challenging in the context of Alzheimer’s disease and related neurodegenerative dementias. These diseases last for years yet affect cognitive and communication abilities early in the disease course.

This project addresses the gap in dementia-specific advance care planning and medical treatment decisions for clinicians who provide primary care. Specifically, the training uses 4 video-based advance care planning scenarios and an accompanying training toolkit. Furthermore, trained clinicians are assessed for actual application of these skills in their clinical encounters. In addition, the training modules are disseminated through collaboration with Vital Talk.

The is a T32 training application specifically focused on training physicians (MDs, DOs). The focus is clinical/translational and/or health services research at the interface of Geriatrics and Oncology. The central component of ºÚÁÏÍø-GO training is the mentored research experience. Trainees choose between two research tracks that represent the best research areas that ºÚÁÏÍø has to offer. Furthermore, these two tracks are clinical/translational research and health services research. Additionally, under the guidance of the mentoring team, trainees design and conduct one or more independent projects.

Dr. Hyman Muss, Vice Chair of Hematology/Oncology and Dr. Jan Busby-Whitehead, Geriatric Medicine Division Chief, are Co-Principal Investigators and lead the . This program trains fellows in Medical Oncology and Geriatric Medicine through several pathways.

ºÚÁÏÍø’s Division of Geriatric Medicine is one of seven national Medical Students Training in Aging Research (MSTAR) training centers. It has been funded since 2010. The National Institute on Aging (NIA) sponsors this program to connect medical students with mentored research opportunities and academic experiences. Mentorship helps to advance students’ knowledge of aging. It also exposes them to broad possibilities for basic science, clinical, and health services research.